GB202303387D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB202303387D0
GB202303387D0 GBGB2303387.1A GB202303387A GB202303387D0 GB 202303387 D0 GB202303387 D0 GB 202303387D0 GB 202303387 A GB202303387 A GB 202303387A GB 202303387 D0 GB202303387 D0 GB 202303387D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2303387.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thirtyfivebio Ltd
Original Assignee
Thirtyfivebio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thirtyfivebio Ltd filed Critical Thirtyfivebio Ltd
Priority to GBGB2303387.1A priority Critical patent/GB202303387D0/en
Publication of GB202303387D0 publication Critical patent/GB202303387D0/en
Priority to PCT/GB2024/050610 priority patent/WO2024184650A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB2303387.1A 2023-03-08 2023-03-08 Compounds Pending GB202303387D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2303387.1A GB202303387D0 (en) 2023-03-08 2023-03-08 Compounds
PCT/GB2024/050610 WO2024184650A1 (en) 2023-03-08 2024-03-07 Bicyclic heteroaryl compounds for use as gpr35 modulators.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2303387.1A GB202303387D0 (en) 2023-03-08 2023-03-08 Compounds

Publications (1)

Publication Number Publication Date
GB202303387D0 true GB202303387D0 (en) 2023-04-19

Family

ID=85980348

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2303387.1A Pending GB202303387D0 (en) 2023-03-08 2023-03-08 Compounds

Country Status (2)

Country Link
GB (1) GB202303387D0 (en)
WO (1) WO2024184650A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005119252A2 (en) 2004-05-26 2005-12-15 Arena Pharmaceuticals, Inc. Modulators of gpr35 for the treatment of metabolic-related disorders
US20100197688A1 (en) * 2008-05-29 2010-08-05 Nantermet Philippe G Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancer
WO2015143376A1 (en) * 2014-03-21 2015-09-24 Nivalis Therapeutics, Inc. Novel compounds for the treatment of cystic fibrosis
TWI845600B (en) * 2019-01-24 2024-06-21 美商普羅米修斯生物科學股份有限公司 Gpr35 modulators
CN114466844A (en) * 2019-10-02 2022-05-10 康佳诺医疗科技发展有限公司 N- (1H-imidazol-2-yl) benzamide compounds and pharmaceutical compositions containing the same as active ingredient
AU2022270411A1 (en) * 2021-05-05 2023-11-23 University College Cardiff Consultants Limited Heteroaryl compounds useful in the treatment of cognitive disorders

Also Published As

Publication number Publication date
WO2024184650A1 (en) 2024-09-12

Similar Documents

Publication Publication Date Title
GB202200735D0 (en) Compounds
GB202201996D0 (en) Compounds
GB202305212D0 (en) Compounds
GB202303419D0 (en) Compounds
GB202303387D0 (en) Compounds
GB202303230D0 (en) Compounds
GB202302871D0 (en) Compounds
GB202302237D0 (en) Tryptophan-based compounds
GB202302032D0 (en) Compounds
GB202301024D0 (en) Compounds
GB202301012D0 (en) Compounds
GB202301008D0 (en) Compounds
GB202301000D0 (en) Compounds
GB202300995D0 (en) Compounds
GB202300922D0 (en) Compounds
GB202300021D0 (en) Compounds
GB202219706D0 (en) Compounds
GB202219534D0 (en) Compounds
GB202217844D0 (en) Compounds
GB202217330D0 (en) Compounds
GB202216695D0 (en) Compounds
GB202215664D0 (en) Compounds
GB202215534D0 (en) Compounds
GB202214800D0 (en) Compounds
GB202214796D0 (en) Compounds